These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25268801)

  • 1. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
    Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C
    PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
    Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
    Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
    Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
    Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
    Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
    PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of DPP-IV inhibition in NOD mice with overt diabetes.
    Vargová L; Zacharovová K; Dovolilová E; Vojtová L; Cimburek Z; Saudek F
    Folia Biol (Praha); 2013; 59(3):116-22. PubMed ID: 23890479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.
    Mehta DS; Christmas RA; Waldmann H; Rosenzweig M
    Immunology; 2010 May; 130(1):103-13. PubMed ID: 20059577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes.
    You S; Piali L; Kuhn C; Steiner B; Sauvaget V; Valette F; Clozel M; Bach JF; Chatenoud L
    PLoS One; 2013; 8(10):e77296. PubMed ID: 24204793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homotaurine Treatment Enhances CD4
    Tian J; Dang H; O'Laco KA; Song M; Tiu BC; Gilles S; Zakarian C; Kaufman DL
    Immunohorizons; 2019 Oct; 3(10):498-510. PubMed ID: 31636084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies.
    Yi Z; Diz R; Martin AJ; Morillon YM; Kline DE; Li L; Wang B; Tisch R
    Diabetes; 2012 Nov; 61(11):2871-80. PubMed ID: 22751694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 modulates diabetes onset in nonobese diabetic mice.
    Hadjiyanni I; Baggio LL; Poussier P; Drucker DJ
    Endocrinology; 2008 Mar; 149(3):1338-49. PubMed ID: 18063685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
    Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    Am J Pathol; 2008 Apr; 172(4):972-9. PubMed ID: 18349126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
    Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
    Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice.
    Mollah ZU; Graham KL; Krishnamurthy B; Trivedi P; Brodnicki TC; Trapani JA; Kay TW; Thomas HE
    PLoS One; 2012; 7(7):e40357. PubMed ID: 22792290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Galactosylceramide ameliorates autoimmune diabetes in non-obese diabetic mice through a suppressive effect mediated by CD8+ T cells.
    Chuang YP; Lin YC; Sytwu HK
    Immunol Lett; 2011 Jul; 138(1):54-62. PubMed ID: 21392534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice.
    Suarez-Pinzon WL; Rabinovitch A
    Cell Transplant; 2011; 20(9):1343-9. PubMed ID: 21396168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.
    Sarikonda G; Sachithanantham S; Manenkova Y; Kupfer T; Posgai A; Wasserfall C; Bernstein P; Straub L; Pagni PP; Schneider D; Calvo TR; Coulombe M; Herold K; Gill RG; Atkinson M; Nepom G; Ehlers M; Staeva T; Garren H; Steinman L; Chan AC; von Herrath M
    PLoS One; 2013; 8(2):e54712. PubMed ID: 23405091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
    Kaminitz A; Mizrahi K; Askenasy N
    Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.